| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.24 | 6e-08 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |